Lactibiane Reference

Name: Lactibiane Reference
SKU: 7046
Availability: InStock

4 Strains · 10 Billion CFU · IBS-Constipation Predominant

Price range: 138.26 SAR through 258.82 SAR

Option

Clear

SKU: N/A Categories: Gut Health, Lactibiane®, Microbiome Intelligence, PiLeJe

Clinical Problem

Irritable Bowel Syndrome with constipation (IBS-C) is among the most prevalent and undertreated gastrointestinal disorders. Dysbiosis — characterised by reduced microbial diversity, decreased Lactobacillus/Bifidobacterium abundance, and disrupted gut-brain axis signalling — is central to its pathophysiology.

Target Patient

Adults with IBS-C (constipation-predominant IBS)

Chronic bloating and abdominal discomfort

Post-antibiotic gut dysbiosis

Patients seeking BSG-endorsed, evidence-based probiotic therapy

Product Benefits

IBS-C Symptom Reduction

BSG 2021 endorsed. 4 targeted strains selected for IBS-C clinical efficacy — reducing frequency and severity of constipation episodes.

Microbiota Rebalancing

10 Billion CFU · restores Lactobacillus and Bifidobacterium populations disrupted in IBS patients.

Gut-Brain Axis Support

Probiotic modulation of the enteric nervous system. Reduction in visceral hypersensitivity — less pain and bloating.

Guideline-Endorsed

BSG 2021 guidelines endorse probiotic therapy as an adjunct in IBS management. NICE and WGO supported.

Treatment Areas

IBS-C

Chronic constipation

Post-antibiotic dysbiosis

Microbiota rebalancing

Product Composition

4 Probiotic Strains	Targeted strain selection for IBS-C clinical efficacy · Lactobacillus and Bifidobacterium species
10 Billion CFU	Per Sachets · HQM® certified viability at end of shelf life
Strain Selection	Evidence-based · BSG 2021 guideline-aligned strain criteria
Format	Oral capsule · 10 or 30 Sachets packs · Room temperature stable

Clinical Results

4 Strains

IBS-C Targeted

10B CFU

Per Sachets

BSG 2021

Endorsed

NICE

CG61 Supported

WGO

Supported

HQM®

Certified

Treatment Protocol

Indication

IBS-C

Constipation-predominant IBS

Dosage

1 Sachets / Day

With morning meal

Duration

4–8 Weeks

Minimum course · ongoing as required

Format

Oral Sachets

10 or 30-Sachets pack

Treatment Areas

IBS-C · Chronic constipation · Post-antibiotic dysbiosis · Microbiota rebalancing

Frequently Asked Questions

How long before effects are noticed?

Most patients report improvement in bowel regularity and reduction in bloating within 2–4 weeks of consistent daily use. Full microbiota rebalancing typically occurs over 4–8 weeks.

Can Lactibiane Reference be taken long-term?

Yes. Long-term probiotic supplementation is safe and increasingly supported for chronic IBS management. BSG 2021 guidelines support ongoing use in symptomatic patients.

Scientific References

British Society of Gastroenterology (BSG) 2021 guidelines — probiotic therapy in IBS
NICE CG61 — IBS management guidelines · probiotic adjunct recommendation
World Gastroenterology Organisation (WGO) probiotic guide · IBS-C strain evidence table

Duration

All clinical data referenced from published peer-reviewed sources. For professional use by qualified healthcare providers only. Not for patient self-diagnosis or treatment.